Empowering clinicians with technologies that solve real challenges.

About Us

About Keya Medical

Keya Medical is dedicated to the development and commercialization of deep learning-based medical devices for disease diagnosis and treatment with a goal to revolutionize the medical device industry.

Keya Medical’s team of 407 employees combines expertise in deep learning, computer vision, medical image processing, fluid dynamics, and medical robotics. Many of our research and development team members previously worked at world-renowned medical device companies and were deeply involved in the successful development of leading medical devices. Our multidisciplinary expertise allows us to provide solutions that address the most pressing challenges facing clinicians today.

Keya Medical has developed solutions for specialties including cardiology, neurology, radiology, pathology, and surgery. We are proud to collaborate with 728 hospitals to bring solutions to clinical use that improve diagnostics, care processes, and clinical outcomes.

By the Numbers


Collaboration Partners

Registered Patents



Keya Medical is founded


Keya Medical establishes the first AI diagnostic laboratory in China

DeepVessel FFR enters the CFDA Special Approval Channel for Innovative Medical Devices

Keya Medical receives ISO 13485 certification

DeepVessel FFR receives CE Mark


Keya Medical is selected to the Top 100 Medical Companies of the Future list by VCBeat Research

DeepVessel FFR becomes the first Class-III AI medical device approved for clinical use by the Chinese National Medical Products Administration

Keya Medical raises over $15 million in strategic funding

CuraRad-ICH receives U.S. FDA 510(k) clearance

Keya Medical closes $20 million in Series B+ funding

Keya Medical is awarded China’s Most Promising Company Award by Ernst & Young Fudan China
CuraRad-ICH joins Nuance AI Marketplace for Diagnostic Imaging

Keya Medical closes $30 million in Series C funding

Keya Medical raises $46 million in Series D funding

DeepVessel FFR demonstrates an accuracy of 92% in a single-center retrospective study conducted by researchers at Fuwai Hospital

Keya Medical’s President of R&D, Dr. Kunlin Cao, is recognized on the 2021 Forbes China Up-and-Coming Businesswomen list

Researchers at the First Affiliated Hospital of Jinan University conduct a single-centered retrospective study on DVFFR


DeepVessel FFR received FDA clearance

Industry Recognition

Keya Medical is a leading medical technology company with triple certification of China NMPA, EU CE, and US FDA


January 2020

DeepVessel® FFR


August 2018

DeepVessel® FFR


April 2020

CuraRad® ICH

April 2022

DeepVessel® FFR

Keya Medical wins the Frontier Technology Award at the China Medical Equipment Fair (CMEF) 2021

Keya Medical is ranked sixth on the Top 100 Medical Companies of the Future List by VCBeat Research

Keya Medical is named to the list of Top Ten Industrial Upgrades of the Year by Laifeng.com

Dr. Kunlin Cao is named to the 2021 Forbes China Up-and-Coming Businesswomen List

Keya Medical wins the 2020 Most Growth Enterprise Award at the New Economy Industry Annual Summit Awards Ceremony hosted by iiMedia Research

Keya Medical is selected as one of the top 50 Global Healthcare Technology Companies at World Innovators Meet (WIM) 2020

Keya Medical is recognized by VCBeat as one of China’s Top 100 Medical Companies and DeepVessel FFR is named one of the TOP 5 FFR Products in China
Keya Medical is awarded the 2020 Best Commercial Growth Award by Laifeng.com
Keya Medical wins the 2020 Most Innovative Company Award at the 9th Annual China Finance Summit

Keya Medical wins the 2020 Ernst and Young Fudan China’s Most Promising Company Award

Keya Medical wins the 2020 China Health Industry Award for “Intelligent Medical Innovative Enterprise”

Keya Medical wins the 2020 Digital China Innovation Competition in Fuzhou for the Smart Medical Track